Skip to main content

Davis Polk & Wardwell and Global Law Office are advising medical research firm CARsgen Therapeutics on its planned IPO in Hong Kong, with Herbert Smith Freehills and Zhong Lun Law Firm advising the joint underwriters. The IPO is expected to raise up to $400 million.

CARsgen is a biopharmaceutical company established in 2014, with operations in China and the U.S. It focuses on CAR-T cell therapies for the treatment of hematological malignancies and solid tumors.

Maples and Calder is providing the issuer offshore legal advice. The joint underwriters are Goldman Sachs and UBS.

Related Articles

Deals

Khaitan, SAM, Sidley advise on Torrent Power’s $413 mln QIP

by Nimitt Dixit |

Indian law firm Khaitan & Co has advised Torrent Power on its equity offering of $413 million through a qualified institutional placement of shares. Shardul Amarchand Mangaldas & Co and Sidley Austin advised the bookrunning lead managers on the deal.

Deals

IndusLaw guides Zepto’s $350 mln funding round

by Nimitt Dixit |

IndusLaw has guided Indian quick commerce company Zepto on its latest $350 million funding round led by Motilal Oswal's Private Wealth division.

Deals

9 firms advise on milestone $8.2 bln cross-border insurance deal

by Sarah Wong |

Global law firms Debevoise & Plimpton, Kirkland & Ellis and Herbert Smith Freehills are acting for Bermuda-based insurer Resolution Life on its $8.2 billion sale to Japan’s Nippon Life Insurance, the largest overseas acquisition by a Japanese insurer to date.